title: A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII.
abstract: We have constructed new B domain deletion derivatives of human factor VIII (FVIII) by manipulating the cDNA using recombinant DNA techniques. One of these new derivatives, FVIII delta II, in which amino acids 771(pro)-1666(asp) have been deleted, no longer contains the protease cleavage site at amino acid position 1648(arg)-1649(glu) known to be involved in the initial step of FVIII processing. We have expressed this molecule in both baby hamster kidney (BHK) 21 cells using the vaccinia virus (VV) expression system and have established Chinese hamster ovary (CHO) derived permanent cell lines expressing either recombinant (r)FVIII or FVIII delta II. The characteristics of FVIII delta II have been compared to those of rFVIII and/or plasma derived (pd) FVIII. FVIII delta II has the following properties: (i) it exhibits FVIII procoagulant activity; (ii) it is expressed at 5-fold higher levels than is the complete molecule in comparable systems; (iii) it migrates for the most part as a single major band on SDS-PAGE, in contrast to the complete molecule; (iv) it is activated to a greater extent by thrombin than is either rFVIII or pdFVIII; and (v) it retains the ability to bind von Willebrand factor (vWf).
authors.affiliation: Department of Molecular and Cellular Biology, TRANSGENE SA, Strasbourg, France.
authors.forename: P
authors.initials: P
authors.lastname: Meulien
authors.forename: T
authors.initials: T
authors.lastname: Faure
authors.forename: F
authors.initials: F
authors.lastname: Mischler
authors.forename: H
authors.initials: H
authors.lastname: Harrer
authors.forename: P
authors.initials: P
authors.lastname: Ulrich
authors.forename: B
authors.initials: B
authors.lastname: Bouderbala
authors.forename: K
authors.initials: K
authors.lastname: Dott
authors.forename: M
authors.initials: M
authors.lastname: Sainte Marie
authors.forename: C
authors.initials: C
authors.lastname: Mazurier
authors.forename: M L
authors.initials: ML
authors.lastname: Wiesel
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D000941:Antigens / Q000096:biosynthesis / Q000235:genetics* / Q000276:immunology; D001673:Biodegradation, Environmental; D004247:DNA / Q000096:biosynthesis*; D005169:Factor VIII / Q000096:biosynthesis / Q000235:genetics*; D005818:Genetic Engineering; D005822:Genetic Vectors; D010447:Peptide Hydrolases / Q000378:metabolism; D010957:Plasmids; D011233:Precipitin Tests; D011994:Recombinant Proteins / Q000096:biosynthesis; D013917:Thrombin / Q000235:genetics / Q000378:metabolism; D014162:Transfection; D014841:von Willebrand Factor / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000941:Antigens; D011994:Recombinant Proteins; C029417:Von Willebrand antigen; D014841:von Willebrand Factor; D005169:Factor VIII; D004247:DNA; D010447:Peptide Hydrolases; D013917:Thrombin